Why wooo ashtool?
RECENT HIGHLIGHTS
$3.7 million cash burn
- Record quarter for ADAPT sales which continue to accelerate.
- Net cash outflows reduced by 23% over the previous quarter (excluding the R&D rebate).
- Quarterly underlying sales1 are up 16% on the prior quarter.
- Two separate patent applications for TAVR technologies were filed in the
US.
- A new funding facility was arranged for up to $10.0M in secured debt from Partners for Growth (after quarter close).
- Entered into an exclusive supply agreement for TMVR with 4C Medical.
- CardioCel® 3D moved from a pre-market programme to an expanded
access programme.
- The new Royal Adelaide Hospital (nRAH) officially opened on
5 September 2017 – poised to positively impact infusion business sales.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
Why wooo ashtool? RECENT HIGHLIGHTS Record quarter for ADAPT...
-
- There are more pages in this discussion • 184 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$10.90 |
Change
-0.900(7.63%) |
Mkt cap ! $230.4M |
Open | High | Low | Value | Volume |
$11.85 | $11.90 | $10.65 | $1.718M | 157.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $10.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.00 | 13000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 10.800 |
1 | 1000 | 10.700 |
1 | 5000 | 10.610 |
5 | 24854 | 10.500 |
4 | 1200 | 10.000 |
Price($) | Vol. | No. |
---|---|---|
11.000 | 13000 | 2 |
11.250 | 1000 | 1 |
11.600 | 8 | 1 |
11.990 | 999 | 1 |
12.100 | 1220 | 1 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |